Back
Baxter International Vs. Perspective Therapeutics Industry Stock Comparison
Sell
41
BAX
Baxter International
Last Price:
36.51
Seasonality Move:
3.48%
Buy
84
CATX
Perspective Therapeutics
Last Price:
1.85
Seasonality Move:
3.58%
Sell
41
Baxter International (BAX)
is a Sell
Is Baxter International a Buy, Sell or Hold?
- The current Baxter International [BAX] share price is $36.89. The Score for BAX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- BAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
84
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.81. The Score for CATX is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
BAX Stock Price Chart
What is Baxter International's stock price today?
-
The Baxter International share price today is $36.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BAX is experiencing slight selling pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing slight buying pressure.
BAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.86 | Sell |
| Relative Strength Index (14 RSI): | 26.64 | Sell |
| Chaikin Money Flow: | -1003909 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.12 - 42.54) | Sell |
| Bollinger Bands (100): | (38.6 - 42.14) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 71.56 | Buy |
| Chaikin Money Flow: | 940587 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.42 - 1.66) | Buy |
| Bollinger Bands (100): | (0.51 - 1.39) | Buy |
BAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.56 | Sell |
| 20-day SMA: | 40.28 | Sell |
| 50-day SMA: | 41.53 | Sell |
| 200-day SMA: | 39.35 | Sell |
| 8-day EMA: | 39.03 | Sell |
| 20-day EMA: | 40.08 | Sell |
| 50-day EMA: | 40.67 | Sell |
| 200-day EMA: | 40.85 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.68 | Buy |
| 20-day SMA: | 1.58 | Buy |
| 50-day SMA: | 1.32 | Buy |
| 200-day SMA: | 0.65 | Buy |
| 8-day EMA: | 1.69 | Buy |
| 20-day EMA: | 1.58 | Buy |
| 50-day EMA: | 1.34 | Buy |
| 200-day EMA: | 0.82 | Buy |
Baxter International Earnings Growth & BAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.03 per share, an increase this year of $0.33 per share, and an increase next year of $0.31 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Baxter International Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||